Assessing the capacity of available pharmaceuticals to protect human PSC-derived cardiomyocytes from anthracycline cardiotoxicity
Open Access
- 14 November 2026
- journal article
- research article
- Published by Springer Nature in Scientific Data
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Future Fund (MRF2024440)
- Medical Research Future Fund (MRF2024440)
- Medical Research Future Fund (MRF2024440)
- Medical Research Future Fund (MRF2024440)
- Kids' Cancer Project
- Children’s Cancer Foundation
- Royal Children’s Hospital Foundation
- National Health and Medical Research Council of Australia (GNT2008376)
- Stafford Fox Medical Research Foundation
- The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW (NNF21CC0073729)
- The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW (NNF21CC0073729)
- National Heart Foundation of Australia (GNT105525)